By knowing what to watch for and communicating with your healthcare professional, you can stay in control of your health.
Andr-Lvigne D, Pignel R, Boet S, Jaquet V, Kalbermatten DF, Madduri S
Losing Weight with Semaglutide It is a GLP-1 (glucagon-like-peptide-1) receptor agonist
Research Results Clinically tested for skin irritation on sensitive Skin Clinically tested for non-comedogenic After a single application, more than 85 % of the skin hydration lasted for up to 24 hours.* *Clinical testing in 20 people
44,45 In a meta-analysis of 48 RCTs including 27,729 participants, the overall incidence of GI adverse events was reported to be 11.6%, with nausea identified as the most common symptom (21.4%)